Related Experiment Videos
Norepinephrine-augmenting lipolytic effectors from Astilbe thunbergii rhizomes
L K Han1, H Ninomiya, M Taniguchi
1Second Department of Medical Biochemistry, School of Medicine, Ehime University, Shigenobu-cho, Onsen-gun, Ehime 791-0295, Japan.
Journal of Natural Products
|August 29, 1998
Summary
Rhizomes of Astilbe thunbergii contain compounds that enhance fat breakdown (lipolysis) and inhibit fat production (lipogenesis). These natural compounds show potential for metabolic research and therapeutic applications.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Metabolic Research
Background:
- Astilbe thunbergii rhizomes are traditionally used in herbal medicine.
- Understanding the bioactive compounds in medicinal plants is crucial for drug discovery.
Purpose of the Study:
- To investigate the lipolytic and lipogenic effects of Astilbe thunbergii rhizome extracts.
- To identify the specific compounds responsible for these effects.
Main Methods:
- Extraction of Astilbe thunbergii rhizomes using 80% Me2CO and EtOAc.
- Assay of norepinephrine-induced lipolysis in rat fat cells.
- Isolation and identification of active compounds using chromatographic and spectroscopic techniques.
- Evaluation of compound effects on lipolysis and lipogenesis.
Main Results:
- An EtOAc-soluble fraction significantly enhanced norepinephrine-induced lipolysis.
- Eucryphin, bergenin, and astilbin were identified as the active compounds.
- These compounds enhanced lipolysis and slightly stimulated ACTH-induced lipolysis.
- They also inhibited insulin-induced lipogenesis from glucose.
Conclusions:
- Astilbe thunbergii rhizomes possess compounds with significant lipolytic and lipogenic regulatory activities.
- Eucryphin, bergenin, and astilbin are key bioactive constituents with potential metabolic implications.
- Further research into these compounds may yield novel therapeutic agents for metabolic disorders.